Baxter International Shares Nudge Higher Despite Poor Market Performance

☀️Trending News

Baxter International ($NYSE:BAX) Inc. is a leading health care company focused on providing innovative products and services to hospitals, dialysis centers, nursing homes, and other medical facilities all over the world. This marginal growth was the result of Baxter International’s consistent efforts to create sustainable value for its investors. The company is dedicated to creating new ways to deliver enhanced patient care while reducing health care costs. It has recently announced its new strategic plan, which includes critical steps to increase the company’s operational efficiencies and improve its portfolio of products and services. The company has also invested in research and development to create innovative products that benefit patients and health care providers. Its most recent achievement was the approval of its new drug in Spain.

This drug is expected to improve the quality of life for patients suffering from rare genetic disorders. Despite the challenging environment, Baxter International continues to post strong financial performance. As a result of Baxter International’s consistent efforts to create long-term value for its investors, its shares experienced a slight increase despite the overall poor market performance. This resilience suggests that Baxter International Inc. remains a solid investment opportunity in the long run.

Market Price

Shares of Baxter International Inc. (BAX) nudged higher on Friday despite a generally poor market performance. Investors seemed to be encouraged by the steady gains despite a generally bearish market outlook. There was no major news driving the stock, but analysts point to the company’s strong fundamentals and proven track record in the medical supplies and services industry. As such, even amidst a volatile market, Baxter International Inc. looks to be an attractive investment option for those seeking to benefit from the long-term prospects of the industry. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Baxter International. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Baxter International. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Baxter International. More…

Key Ratios Snapshot

Some of the financial key ratios for Baxter International are shown below. More…

Analysis

At GoodWhale, we have conducted an in-depth analysis of the fundamentals of BAXTER INTERNATIONAL. Based on our Star Chart tool, we found that BAXTER INTERNATIONAL is strong in dividend, medium in profitability and weak in asset and growth. In other words, BAXTER INTERNATIONAL is classified as a ‘rhino’ – a type of company that has achieved moderate revenue or earnings growth. Considering the fact that BAXTER INTERNATIONAL has a high health score of 7/10, we believe that the company is capable to safely ride out any crisis without the risk of bankruptcy. This may be attractive to conservative investors who are looking for investments with low risk but reliable returns. Moreover, investors with a medium to long-term investment time horizon may also be interested in such a company. More…

Peers

Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.

– Utah Medical Products Inc ($NASDAQ:UTMD)

The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.

– Clarity Medical Group Holding Ltd ($SEHK:01406)

According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.

– Merit Medical Systems Inc ($NASDAQ:MMSI)

Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.

Summary

Baxter International Inc. shares closed 0.07% higher at $43.94 on Thursday, amid a weak trading day on the markets. Investors are advised to consider the company’s long-term fundamentals and financial performance before investing in the stock. Analysts recommend looking at Baxter’s balance sheet, evaluating recent dividend trends and studying the company’s P/E ratio to gauge its value.

Analysts advise investors to consider how macroeconomic factors, such as market volatility, could affect their investment decisions. Overall, Baxter International is a solid stock choice for conservative investors looking for a safe and reliable investment.